Segal Lloyd Mitchell's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Apr 1, 2024
- Accession no.
- 0001415889-24-009629
- Filed
- Apr 1, 2024
- Trade date
- Mar 28-Apr 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $23.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Segal Lloyd MitchellCIK 0001477123 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | Common Shares | SSaleDisposed | −2,650 | $4.62 | −$12,243 | 110,049 | Indirect | |
| Apr 1, 2024 | Common Shares | SSaleDisposed | −2,491 | $4.63 | −$11,533.33 | 107,558 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.